ANNAROSE ZAMPANO: Open Payments
NPI 1417681131 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$260 in 14 payments from 7 companies in 2025. Trend: 2023 $57 · 2024 $92 · 2025 $260
Food & beverage: $260
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $153 |
| Astellas Pharma US Inc | 1 | $23 |
| Radius Health, Inc. | 1 | $20 |
| Sonex Health, Inc. | 1 | $17 |
| Gilead Sciences, Inc. | 1 | $16 |
| Novo Nordisk Inc | 1 | $15 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: VRAYLAR, QULIPTA, UBRELVY, Veozah, Tymlos, SX-ONE MICROKNIFE, Ozempic, JARDIANCE.
Industry payments across UT — which companies pay providers there.
